Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
Makoto Isono(Heinrich Heine University Düsseldorf), Akinori Sato(National Defense Medical College)
Cited by 22
Related Papers
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
|Journal of Experimental & Clinical Cancer Research|2017|81
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
|Cancer Science|2019|50
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells
|Anticancer Research|2018|24
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
|Anticancer Research|2018|11
Simvastatin-Romidepsin Combination Kills Bladder Cancer Cells Synergistically
|Research Square|2020|2